The sales of valves to meet the rigid requirements of the pharmaceutical, food and other life science industries in 2015 will exceed $3.4 billion worldwide. This is the last forecast in Industrial Valves World Market published by the McIlvaine Company.
Traditionally, Europe and the U.S. have been the big markets for pharmaceutical valves. The rapid construction of generic manufacturing facilities in India and China, along with a general trend to build manufacturing facilities close to the market, is creating a market shift toward Asia.
Much of the growth in food processing is also in Asia where there is a growth in production along with greater concern for contamination. This increases the average sales price per valve as more expensive materials of construction and more expensive designs are needed. The food industry also has need for valves which can withstand the higher temperatures associated with safe processing.
"Other Life Sciences" include cosmetics and a number of small niche applications. Valves used in hospitals are not included in these industrial forecasts.
The market for valves for municipal drinking water plants in 2015 will be more than $3.8 billion. However, these valves are not designed to the high sanitary levels required of valves in the life sciences. One reason is that disinfection is a common method of protection of drinking water, but is not acceptable as a way to treat fluids processed in the life sciences.
The life sciences segment of the valve market has grown more steadily and at a higher rate than the average segment.
Picture: McIlvaine Company